nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—adipose tissue—metabolic syndrome X	0.0391	0.123	CbGeAlD
Carfilzomib—PSMB10—liver—metabolic syndrome X	0.0274	0.0863	CbGeAlD
Carfilzomib—PSMB8—adipose tissue—metabolic syndrome X	0.0252	0.0793	CbGeAlD
Carfilzomib—PSMB5—adipose tissue—metabolic syndrome X	0.0223	0.0701	CbGeAlD
Carfilzomib—PSMB1—cardiovascular system—metabolic syndrome X	0.0221	0.0694	CbGeAlD
Carfilzomib—PSMB1—kidney—metabolic syndrome X	0.0216	0.068	CbGeAlD
Carfilzomib—PSMB2—cardiovascular system—metabolic syndrome X	0.0215	0.0678	CbGeAlD
Carfilzomib—PSMB2—kidney—metabolic syndrome X	0.0211	0.0663	CbGeAlD
Carfilzomib—PSMB1—adipose tissue—metabolic syndrome X	0.0195	0.0612	CbGeAlD
Carfilzomib—PSMB2—adipose tissue—metabolic syndrome X	0.019	0.0598	CbGeAlD
Carfilzomib—PSMB8—liver—metabolic syndrome X	0.0177	0.0556	CbGeAlD
Carfilzomib—PSMB5—liver—metabolic syndrome X	0.0156	0.0491	CbGeAlD
Carfilzomib—PSMB1—liver—metabolic syndrome X	0.0136	0.0429	CbGeAlD
Carfilzomib—PSMB2—liver—metabolic syndrome X	0.0133	0.0419	CbGeAlD
Carfilzomib—ABCB1—blood vessel—metabolic syndrome X	0.00737	0.0232	CbGeAlD
Carfilzomib—ABCB1—cardiovascular system—metabolic syndrome X	0.00329	0.0104	CbGeAlD
Carfilzomib—ABCB1—kidney—metabolic syndrome X	0.00322	0.0101	CbGeAlD
Carfilzomib—ABCB1—adipose tissue—metabolic syndrome X	0.0029	0.00913	CbGeAlD
Carfilzomib—ABCB1—liver—metabolic syndrome X	0.00203	0.0064	CbGeAlD
Carfilzomib—PSMB1—Signaling Pathways—IGF2—metabolic syndrome X	0.000254	0.000372	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF2—metabolic syndrome X	0.000254	0.000372	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF2—metabolic syndrome X	0.000254	0.000372	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—metabolic syndrome X	0.000254	0.000372	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IRS1—metabolic syndrome X	0.000251	0.000368	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IRS1—metabolic syndrome X	0.000251	0.000368	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IRS1—metabolic syndrome X	0.000251	0.000368	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF2—metabolic syndrome X	0.00025	0.000367	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—G6PC2—metabolic syndrome X	0.000249	0.000365	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PPARA—metabolic syndrome X	0.000249	0.000365	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PPARA—metabolic syndrome X	0.000249	0.000365	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PPARA—metabolic syndrome X	0.000249	0.000365	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IRS1—metabolic syndrome X	0.000248	0.000363	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOB—metabolic syndrome X	0.000247	0.000361	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOB—metabolic syndrome X	0.000247	0.000361	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOB—metabolic syndrome X	0.000247	0.000361	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PPARA—metabolic syndrome X	0.000245	0.000359	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—metabolic syndrome X	0.000244	0.000358	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOB—metabolic syndrome X	0.000243	0.000356	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—metabolic syndrome X	0.000243	0.000356	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AGT—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AGT—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AGT—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL5—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL5—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL5—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—INS—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—INS—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—INS—metabolic syndrome X	0.000241	0.000353	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00024	0.000352	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00024	0.000352	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00024	0.000352	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—SERPINE1—metabolic syndrome X	0.000238	0.000349	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—SERPINE1—metabolic syndrome X	0.000238	0.000349	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—SERPINE1—metabolic syndrome X	0.000238	0.000349	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AGT—metabolic syndrome X	0.000238	0.000348	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL5—metabolic syndrome X	0.000237	0.000348	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—INS—metabolic syndrome X	0.000237	0.000348	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000237	0.000347	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOE—metabolic syndrome X	0.000236	0.000346	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOE—metabolic syndrome X	0.000236	0.000346	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOE—metabolic syndrome X	0.000236	0.000346	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LPL—metabolic syndrome X	0.000235	0.000345	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LPL—metabolic syndrome X	0.000235	0.000345	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LPL—metabolic syndrome X	0.000235	0.000345	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—SERPINE1—metabolic syndrome X	0.000235	0.000344	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—APOA1—metabolic syndrome X	0.000233	0.000342	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—APOA1—metabolic syndrome X	0.000233	0.000342	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NOS3—metabolic syndrome X	0.000233	0.000342	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—APOA1—metabolic syndrome X	0.000233	0.000342	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOE—metabolic syndrome X	0.000233	0.000341	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IRS1—metabolic syndrome X	0.000232	0.00034	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NOS3—metabolic syndrome X	0.000232	0.00034	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LPL—metabolic syndrome X	0.000232	0.00034	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IRS1—metabolic syndrome X	0.000231	0.000339	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—APOA1—metabolic syndrome X	0.00023	0.000337	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—AKT1—metabolic syndrome X	0.000229	0.000335	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—AKT1—metabolic syndrome X	0.000228	0.000334	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000225	0.00033	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—INS—metabolic syndrome X	0.000223	0.000326	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—INS—metabolic syndrome X	0.000221	0.000325	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SERPINE1—metabolic syndrome X	0.000221	0.000324	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SERPINE1—metabolic syndrome X	0.000221	0.000324	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SERPINE1—metabolic syndrome X	0.000221	0.000324	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCL2—metabolic syndrome X	0.000219	0.000321	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SERPINE1—metabolic syndrome X	0.000218	0.00032	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL2—metabolic syndrome X	0.000218	0.000319	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF1—metabolic syndrome X	0.000215	0.000315	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF1—metabolic syndrome X	0.000214	0.000314	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—metabolic syndrome X	0.000213	0.000313	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—metabolic syndrome X	0.000212	0.000311	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.000212	0.000311	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—metabolic syndrome X	0.000211	0.000309	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—metabolic syndrome X	0.000211	0.000309	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—metabolic syndrome X	0.000211	0.000309	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—metabolic syndrome X	0.000208	0.000305	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PPARG—metabolic syndrome X	0.000206	0.000301	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PPARG—metabolic syndrome X	0.000206	0.000301	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PPARG—metabolic syndrome X	0.000206	0.000301	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000204	0.0003	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000203	0.000298	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PPARG—metabolic syndrome X	0.000203	0.000297	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—INS—metabolic syndrome X	0.000202	0.000296	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—INS—metabolic syndrome X	0.000202	0.000296	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—INS—metabolic syndrome X	0.000202	0.000296	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AGT—metabolic syndrome X	0.000201	0.000295	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AGT—metabolic syndrome X	0.000201	0.000295	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AGT—metabolic syndrome X	0.000201	0.000295	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.000201	0.000295	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—INS—metabolic syndrome X	0.000199	0.000291	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AGT—metabolic syndrome X	0.000199	0.000291	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOE—metabolic syndrome X	0.000197	0.000289	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEP—metabolic syndrome X	0.000197	0.000289	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOE—metabolic syndrome X	0.000197	0.000289	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEP—metabolic syndrome X	0.000197	0.000289	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEP—metabolic syndrome X	0.000197	0.000289	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOE—metabolic syndrome X	0.000197	0.000289	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—metabolic syndrome X	0.000195	0.000286	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APOA1—metabolic syndrome X	0.000195	0.000286	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APOA1—metabolic syndrome X	0.000195	0.000286	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APOA1—metabolic syndrome X	0.000195	0.000286	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOE—metabolic syndrome X	0.000195	0.000285	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEP—metabolic syndrome X	0.000195	0.000285	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—metabolic syndrome X	0.000194	0.000285	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—metabolic syndrome X	0.000193	0.000283	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—metabolic syndrome X	0.000193	0.000283	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—metabolic syndrome X	0.000193	0.000283	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APOA1—metabolic syndrome X	0.000192	0.000282	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—metabolic syndrome X	0.00019	0.000279	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.000185	0.000271	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000185	0.000271	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—metabolic syndrome X	0.000185	0.000271	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—metabolic syndrome X	0.000185	0.000271	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—metabolic syndrome X	0.000185	0.000271	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—metabolic syndrome X	0.000184	0.00027	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—metabolic syndrome X	0.000183	0.000269	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—metabolic syndrome X	0.000182	0.000267	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000179	0.000263	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—metabolic syndrome X	0.000177	0.000259	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—metabolic syndrome X	0.000177	0.000259	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—metabolic syndrome X	0.000177	0.000259	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IRS1—metabolic syndrome X	0.000176	0.000258	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IRS1—metabolic syndrome X	0.000176	0.000258	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IRS1—metabolic syndrome X	0.000176	0.000258	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.000175	0.000256	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—metabolic syndrome X	0.000174	0.000256	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IRS1—metabolic syndrome X	0.000174	0.000254	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—AKT1—metabolic syndrome X	0.000173	0.000254	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—AKT1—metabolic syndrome X	0.000173	0.000254	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—AKT1—metabolic syndrome X	0.000173	0.000254	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000173	0.000253	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000171	0.00025	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000171	0.00025	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—AKT1—metabolic syndrome X	0.000171	0.00025	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—INS—metabolic syndrome X	0.000169	0.000247	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—INS—metabolic syndrome X	0.000169	0.000247	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—INS—metabolic syndrome X	0.000169	0.000247	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—INS—metabolic syndrome X	0.000166	0.000244	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL2—metabolic syndrome X	0.000166	0.000243	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL2—metabolic syndrome X	0.000166	0.000243	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL2—metabolic syndrome X	0.000166	0.000243	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	0.000166	0.000243	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA5—metabolic syndrome X	0.000164	0.00024	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL2—metabolic syndrome X	0.000164	0.00024	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF1—metabolic syndrome X	0.000163	0.000239	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF1—metabolic syndrome X	0.000163	0.000239	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF1—metabolic syndrome X	0.000163	0.000239	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—metabolic syndrome X	0.000162	0.000237	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—metabolic syndrome X	0.000162	0.000237	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—metabolic syndrome X	0.000162	0.000237	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1—metabolic syndrome X	0.000161	0.000236	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—metabolic syndrome X	0.000159	0.000234	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000156	0.000229	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000155	0.000227	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000155	0.000227	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000155	0.000227	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000153	0.000224	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TRIB3—metabolic syndrome X	0.000152	0.000223	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—metabolic syndrome X	0.00015	0.00022	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—metabolic syndrome X	0.00015	0.000219	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—metabolic syndrome X	0.000148	0.000217	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—metabolic syndrome X	0.000148	0.000217	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—metabolic syndrome X	0.000148	0.000217	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000147	0.000215	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—metabolic syndrome X	0.000146	0.000214	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—metabolic syndrome X	0.00014	0.000205	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—metabolic syndrome X	0.00014	0.000205	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—metabolic syndrome X	0.00014	0.000205	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—metabolic syndrome X	0.000139	0.000203	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—AKT1—metabolic syndrome X	0.000139	0.000203	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—metabolic syndrome X	0.000138	0.000202	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—AKT1—metabolic syndrome X	0.000138	0.000202	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—AKT1—metabolic syndrome X	0.000138	0.000202	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—metabolic syndrome X	0.000138	0.000202	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—AKT1—metabolic syndrome X	0.000137	0.000201	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NAMPT—metabolic syndrome X	0.000137	0.0002	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCK—metabolic syndrome X	0.000136	0.000199	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LIPC—metabolic syndrome X	0.000136	0.000199	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOC3—metabolic syndrome X	0.000135	0.000198	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CETP—metabolic syndrome X	0.000131	0.000192	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—metabolic syndrome X	0.000129	0.000189	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000129	0.000188	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—metabolic syndrome X	0.000128	0.000188	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—AKT1—metabolic syndrome X	0.000128	0.000188	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—AKT1—metabolic syndrome X	0.000127	0.000187	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SCARB1—metabolic syndrome X	0.000125	0.000184	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SREBF1—metabolic syndrome X	0.000122	0.000178	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT2—metabolic syndrome X	0.000118	0.000174	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMGCR—metabolic syndrome X	0.000118	0.000174	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000116	0.00017	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—metabolic syndrome X	0.000114	0.000167	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—metabolic syndrome X	0.000114	0.000167	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—metabolic syndrome X	0.000114	0.000167	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—metabolic syndrome X	0.000112	0.000165	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AKT1—metabolic syndrome X	0.000107	0.000157	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AKT1—metabolic syndrome X	0.000107	0.000156	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	0.000106	0.000155	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	0.000106	0.000155	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—metabolic syndrome X	0.000105	0.000154	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—metabolic syndrome X	0.000105	0.000154	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—metabolic syndrome X	0.000105	0.000154	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—AKT1—metabolic syndrome X	0.000105	0.000154	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—AKT1—metabolic syndrome X	0.000105	0.000154	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—AKT1—metabolic syndrome X	0.000105	0.000154	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—AKT1—metabolic syndrome X	0.000105	0.000153	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—AKT1—metabolic syndrome X	0.000105	0.000153	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—AKT1—metabolic syndrome X	0.000105	0.000153	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—metabolic syndrome X	0.000104	0.000152	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—AKT1—metabolic syndrome X	0.000104	0.000152	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—AKT1—metabolic syndrome X	0.000103	0.000151	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT1—metabolic syndrome X	0.000102	0.00015	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGT1—metabolic syndrome X	0.000102	0.00015	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—metabolic syndrome X	9.78e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—metabolic syndrome X	9.78e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—metabolic syndrome X	9.78e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—metabolic syndrome X	9.72e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—AKT1—metabolic syndrome X	9.71e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—AKT1—metabolic syndrome X	9.71e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—AKT1—metabolic syndrome X	9.71e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—metabolic syndrome X	9.68e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—metabolic syndrome X	9.64e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—AKT1—metabolic syndrome X	9.57e-05	0.00014	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AKT1—metabolic syndrome X	8.97e-05	0.000131	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AKT1—metabolic syndrome X	8.93e-05	0.000131	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOB—metabolic syndrome X	8.68e-05	0.000127	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	8.44e-05	0.000124	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LPL—metabolic syndrome X	8.29e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AKT1—metabolic syndrome X	8.13e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AKT1—metabolic syndrome X	8.13e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AKT1—metabolic syndrome X	8.13e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AKT1—metabolic syndrome X	8.01e-05	0.000117	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CD36—metabolic syndrome X	7.87e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—metabolic syndrome X	7.37e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—metabolic syndrome X	7.37e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—metabolic syndrome X	7.37e-05	0.000108	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARA—metabolic syndrome X	7.32e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—metabolic syndrome X	7.26e-05	0.000106	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AGT—metabolic syndrome X	7.09e-05	0.000104	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—metabolic syndrome X	6.94e-05	0.000102	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA1—metabolic syndrome X	6.87e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AKT1—metabolic syndrome X	6.8e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AKT1—metabolic syndrome X	6.8e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AKT1—metabolic syndrome X	6.8e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AKT1—metabolic syndrome X	6.7e-05	9.82e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARG—metabolic syndrome X	6.05e-05	8.86e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—INS—metabolic syndrome X	5.93e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—metabolic syndrome X	5.44e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—metabolic syndrome X	5.2e-05	7.62e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	4.76e-05	6.97e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AKT1—metabolic syndrome X	2.39e-05	3.5e-05	CbGpPWpGaD
